P2RX7 and graft versus host disease: Using small molecule antagonists/agonists and knockout mice of purinergic molecules, these studies have revealed that ATP is released at sites of inflammation and that P2X7 receptor activation on host antigen presenting cells contributes to the stimulation of donor effector T cells to promote GVHD progression (Wilhelm et al., 2010).